CHICAGO—A survey of general pediatricians showed that 84% of them refer more than two thirds of their adolescent hypertensives to either a nephrologist or cardiologist, researchers reported here at the 22nd Annual Meeting of the American Society of Hypertension.
CHICAGO—Hypertensive patients seem to be ignoring a government-backed diet with proven BP-lowering efficacy, researchers said here at the 22nd Annual Scientific Meeting of the American Society of Hypertension.
CHICAGO—Telmisartan (Micardis HCT), a novel angiotensin receptor blocker (ARB), and the older ARB losartan have similar BP-lowering efficacy in hypertensive patients with diabetic nephropathy, but treatment with the new agent is associated with larger reductions in proteinuria, new findings show.
CHICAGO—A novel beta blocker under FDA review controls BP long term without the adverse effects associated with first-generation beta blockers, according to data presented here at the 22nd Annual Scientific Meeting of the American Society of Hypertension.
CHICAGO—Hypertensive patients basically understand the link between high BP and cardiovascular risk, but wide misconceptions persist, according to data released at the 22nd Annual Scientific Meeting of the American Society of Hypertension.
SAN DIEGO—Stereotactic radiosurgery produces early and durable responses in renal cell carcinoma (RCC) patients with either previously untreated spinal metastases or spinal metastases that have recurred after prior radiotherapy, researchers announced here at the 2007 Annual Meeting of the American Academy of Orthopedic Surgeons.
Overactive bladder (OAB) symptoms in middle-aged or older men are associated with an increased risk of erectile dysfunction (ED).
